At a Glance
  • Study Type: Survey
  • Condition: Premutation or full mutation Fragile X
  • Age: 0–13
  • Sex: All
  • Participant: Parent
  • Location: Home
  • Travel Considerations: No travel required
  • Sponsor: The John Merck Fund

Parents of children ages 0-13 with full or premutation Fragile X needed for a survey

RTI International is conducting a survey to learn about the early needs and experiences of families with children, aged 13 or younger, who have been diagnosed with either the full or the premutation of Fragile X.

The online survey should take about 20–90 minutes to complete, depending on the number of eligible children (see more below). The survey may be completed in more than one sitting.

Eligibility

Parents of children with premutation or full mutation Fragile X that meet one of these age requirements may be eligible to participate:

  • Age 0–7 (under 8)
  • Age 0–13 (under 14) and is the first child diagnosed in family

What to Expect

The survey is online and parents will answer a set of questions for each child:

  • First child diagnosed (age 0–13) — approx. 10 min.
  • Children (age 0–7) — approx. 45 min. each

The survey can be completed all at the same time, or divided into more than one sitting.

FAQs

What are the good things that can happen from this research?

The information you provide will contribute to our understanding of the needs and experiences of families with young children with Fragile X. More specifically, it will help us support families in the Early Check study in North Carolina whose newborns have been diagnosed with Fragile X and inform the design of an early intervention program for these babies.

With any online survey, there is a slight risk of loss of confidentiality. However, the research team will make every effort to keep your information private. Your identifiable information will not be shared with anyone outside the research team. There may be other risks that we do not know about yet.

No. Please note that this survey may ask for names and ages, however we (NFXF) will not have access to that data.

Yes.

The first twenty participants who complete the survey and request a gift card will receive a $50 gift card!

LEARN MORE

A Mom Shares Her and Her Son’s Experience Participating in a Fragile X Clinical Trial »
Diane and her son Joshua volunteered for a clinical trial a little over a year ago. In this heartwarming video, his mom shares how their family made the decision to participate, and what the experience has been like so far.

Dr. Elizabeth Berry-Kravis on the Challenges Inherent in a Clinical Trial »
We asked NFXF scientific advisor, doctor, and clinical researcher Dr. Elizabeth Berry-Kravis to comment on the challenges inherent in a clinical trial.

Clinical Trials From Start to Finish (Webinar) »
Sharyn Lincoln and Katherine Pawlowski of Boston Children’s Hospital speaks with us about how clinical research trials work, what it takes to participate, and what happens after the study.

Outside Resources:

Learn About Clinical Trials »
From ClinicalTrials.gov, maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).

Need More Information?

Review our clinical trial FAQs & Resources to help you with your decision to participate, or reach out to us to answer any additional questions.

Our Most Recent Opportunities
If you arrived on this page through a MyFXResearch Portal search, you can close this window and return to your filtered results. Or start a new search here.

PIXI Study: Parent-Infant Fragile X Intervention

RTI International and the University of North Carolina at Chapel Hill are conducting an early intervention study to learn about the best ways to support early development in infants identified with the full mutation of Fragile X. Babies 0–9 months old with the full mutation, and their caregivers, may be eligible to participate.

Study: Our Fragile X World Registry

Our Fragile X World collects data from families using online surveys and in-person studies. Topics covered include sensory or behavioral challenges, health care experiences, and the impact of Fragile X on families.

Fragile X Premutation Carrier Study at USC

The University of South Carolina is conducting a research study focusing on the range of language, social, and cognitive features that may be associated with variations on the FMR1 gene. Women age 35-75 who are carriers of the Fragile X premutation may be eligible to participate.